Fifth Third Bancorp
TARS icon

Fifth Third Bancorp’s Tarsus Pharmaceuticals TARS Stock Holding History

Fifth Third Bancorp’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$327K Buy
5,201
+278
+6% +$17.8K ﹤0.01% 2331
2026
Q1 		$345K Buy
+4,923
New +$344K ﹤0.01% 2242

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Fifth Third Bancorp's TARS Position: Q2 2026 in Review

Fifth Third Bancorp increased its Tarsus Pharmaceuticals (TARS) stake by 5.6% in Q2 2026, buying an estimated $17.8K and bringing the position to 5,201 shares worth $327K. The position accounts for ﹤0.01% of the portfolio, ranked #2331.

Fifth Third Bancorp first reported a position in TARS in Q1 2026 and has held it in 2 quarters since. The position peaked at $345K in Q1 2026. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Fifth Third Bancorp held 5,201 shares of Tarsus Pharmaceuticals worth $327K as of Q2 2026.
  • Fifth Third Bancorp bought 278 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $17.8K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #2331 holding.
  • Fifth Third Bancorp first reported a position in Tarsus Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Fifth Third Bancorp's Tarsus Pharmaceuticals position peaked at $345K in Q1 2026.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.